Skip to content
Recall Observatory FDA recall evidence

Drug product

Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural use, Rx only, 2 mL Ampule, Warning - May be habit forming, Preservative Free, Manufactured by Akorn, Inc. Lake Forest, IL 60045, NDC 17478-0050-02.

D-0460-2022

January 05, 2022

Class II

Product summary

Firm
Akorn, Inc.
Event
Event 89361
Status
Terminated
Classification
Class II
Quantity
31,510 ampules
Official record key
drug-enforcement:D-0460-2022

Official wording

Reason: Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.

Code information: Lot # 031489A, Expiration 03/31/2022

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent